Annovis Bio, Inc. (ANVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.39 |
| Open | 5.49 |
| Bid | 0.00 x 1400 |
| Ask | 0.00 x 800 |
| Day's Range | 5.20 - 5.56 |
| 52 Week Range | 4.86 - 22.49 |
| Volume | |
| Avg. Volume | 462,154 |
| Market Cap | 58.965M |
| Beta (5Y Monthly) | 1.59 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Apellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus Estimate and revenues beat the same, driven by strong sales of Syfovre.
- Zacks
Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
Blueprint (BPMC) gains from better-than-expected first-quarter 2024 results, driven by robust Ayvakit sales growth. The company raises its revenue guidance for 2024.
- Zacks
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.
© 2024 Yahoo. All rights reserved.